Middle East respiratory syndrome corona-virus (MERS-CoV)

Recent epidemics have included the Zika virus, Ebola, Middle East Respiratory Syndrome, otherwise known as the MERS virus, and avian and and swine flu. Today there is a widespread opioid epidemic throughout the country. Next to President Trump, there have probably been more stories on opioids ...

Researchers report on GS-5734, a promising experimental broad-spectrum antiviral drug, previous studies on GS-5734 have shown that the drug inhibits strains of SARS and MERS coronaviruses that infect human airways and the lower respiratory tract, as well as infection by the Ebola virus.

It starts out looking like the flu a couple of weeks after someone is exposed to the virus, and in about 20% of cases can damage blood vessels and organs to ... with an Austrian biotech company called Themis Bioscience to develop a vaccine for Lassa fever and Middle East respiratory syndrome (MERS).

... vaccines to protect against Middle East respiratory syndrome, or MERS, and Lassa fever. Themis Bioscience, of Vienna, could receive up to $37.5 million to develop and manufacture the vaccines. The privately held company already has Zika and chikungunya virus vaccines in its development pipeline…

The 28-year-old Saudi man is in critical condition after being diagnosed as having MERS-CoV (Middle East respiratory syndrome coronavirus). This is the fourth ... Saudi Arabia's MERS-CoV total cases since 2012 are 1,813, including 735 deaths. ... The company is also developing a Zika virus vaccine.

Ultrastructural details exhibited by a single, spherical-shaped, Middle East respiratory syndrome coronavirus (MERS-CoV) virion. ... The researchers now report that the drug also inhibits murine hepatitis virus, or MHV, which is closely related to several human coronaviruses that can cause respiratory tract ...

... vaccines to protect against Middle East respiratory syndrome, or MERS, and Lassa fever. Themis Bioscience 2, of Vienna, could receive up to $37.5 million to develop and manufacture the vaccines. The privately held company already has Zika and chikungunya virus vaccines in its development pipeline.

Three of the other patients had been exposed to camels, another well-known risk factor for contracting MERS-CoV (Middle East respiratory syndrome coronavirus), before they became ill. ... Though the virus doesn't seem to spread easily from person-to-person, hospital settings seem to be the exception.

A nosocomial outbreak of MERS occurred in a private hospital in Hafr Albatin region, the date of onset of the first case was 23 January 2018; while on 4 ... At the end of January 2018, a total of 2160 laboratory-confirmed cases of Middle East respiratory syndrome (MERS), including 773 associated deaths ...

A 74-year-old Saudi woman from Rafha was diagnosed as having MERS-CoV (Middle East respiratory syndrome coronavirus). She is in stable condition. The probable source of her infection is indirect contact with camels, a likely risk factor for the virus. The new case brings Saudi Arabia's MERS totals ...